CLPTM1L anticorps (Middle Region)
Aperçu rapide pour CLPTM1L anticorps (Middle Region) (ABIN635900)
Antigène
Voir toutes CLPTM1L AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Specificité
- CLPTM1 L antibody was raised against the middle region of CLPTM1
-
Purification
- Affinity purified
-
Immunogène
- CLPTM1 L antibody was raised using the middle region of CLPTM1 corresponding to a region with amino acids KAFTYKAFNTFIDDVFAFIITMPTSHRLACFRDDVVFLVYLYQRWLYPVD
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
CLPTM1L Blocking Peptide, (ABIN939624), is also available for use as a blocking control in assays to test for specificity of this CLPTM1L antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of CLPTM0 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- CLPTM1L (CLPTM1-Like (CLPTM1L))
-
Autre désignation
- CLPTM1L
-
Sujet
- CLPTM1L enhances cisplatin-mediated apoptosis, when overexpressed.
-
Poids moléculaire
- 62 kDa (MW of target protein)
Antigène
-